Buy Dr Reddy's, opportunities in pharma stocks: Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Dr Reddy's Laboratories had a three day sharp correction. Now, that correction may be getting over, at least we got that sense. So, when a strongly trending market corrects and then says, okay, I am going up again, we want to buy. That is exactly the case with Sun Pharmaceutical Industries. After big declines, we said okay, let us go and buy. And, I think for most pharmaceutical companies, the declines are buying opportunities."At 09:20 hrs Dr Reddys Laboratories was quoting at Rs 4,278.35, up Rs 46.50, or 1.10 percent. It has touched an intraday high of Rs 4,280 and an intraday low of Rs 4,240.